Der klinische Fall – Der polyvalente Impfstoff Insol® Dermatophyton bei Patienten mit Equinen Sarkoiden

• Literatur

• 1 Ashrafi GH, Tsirimonaki E, Marchetti B et al. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 2002; 21: 248-259
• 2 Bergvall KE. Sarcoids. Vet Clin Equine 2013; 29: 657-671
• 3 Byam-Cook KL, Henson FM, Slater JD. Treatment of periocular and non-ocular sarcoids in 18 horses by interstitial brachytherapy with iridium-192. Vet Rec 2006; 159 (11) 337-341
• 4 Carr EA, Théon AP, Madewell BR et al. Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res 2001; 62: 1212-1217
• 5 Chambers G, Ellsmore VA, OʼBrien PM et al. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res 2003; 96 (1–2) 141-145
• 6 Chambers G, Ellsmore VA, OʼBrien PM et al. Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 2003; 84: 1055-1062
• 7 Christen-Clottu O, Klocke P, Burger D et al. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus). J Vet Intern Med 2010; 24 (6) 1483-1489
• 8 Dahme E, Weiss E. Grundriss der speziellen pathologischen Anatomie der Haustiere. 5. Aufl.. Stuttgart: Enke; 2007
• 9 Dronov A, Rohwer J. Hinweise für eine immunmodulatorische Wirkung von Insol® Dermatophyton auf equine Leukozyten in vitro. Abstractheft der XVII. Tagung über Pferdekrankheiten im Rahmen der Equitana 2007; 102 und Vet-MedReport, Sonderausgabe V4I 2007; 13.
• 10 Gehlen H. Häufige Tumoren-Vorkommen und Therapie: Equines Sarkoid. Vortragsveranstaltung Pferdekrankheiten, 26. Bayerische Tierärztetage 2013; 268-271
• 11 Gerber H. Sir Frederick Hobday memorial lecture. The genetic basis of some equine diseases. Equine Vet J 1989; 21: 244-248
• 12 Kemp-Symonds JG. The detection and sequencing of bovine papillomavirus type 1 and 2 DNA from Musca autumnalis (Diptera: Muscidae) face flies infesting sarcoid-affected horses [MSc thesis]. London, UK: Royal Veterinary College; 2000
• 13 Knottenbelt DC, Kelly DF. The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999. Vet Ophtal 2000; 3: 169-191
• 14 Mählmann K, Hamza E, Marti E et al. Increased FOXP3 expression in tumor-associated tissues of horses affected with equine sarcoid disease. Vet J 2014; 202 (3) 516-521
• 15 Marchetti B, Ashrafi GH, Tsirimonaki E et al. The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents ist transport to the cell surface. Oncogene 2002; 21: 7808-7816
• 16 Martens A, De Moor A, Ducatelle R. PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids. Vet J 2001; 161: 280-286
• 17 Martens A, De Moor A, Demeulemeester J, Peelman L. Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA. Vet Surg 2001; 30: 460-467
• 18 Martens A, De Moor A, Vlaminck L et al. Evaluation of excision, cryosurgery and local BCG vaccination for treatment of equine sarcoids. Vet Rec 2001; 145: 665-669
• 19 Müller H. Papillomatosis of cattle and its relationship to equine sarcoid. Tierarztl Prax 1991; 19: 39-43
• 20 Nasir L, Campo MS. Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet Dermatol 2008; 19 (5) 243-254
• 21 Schaufuß P, Steller U. Grundlagen der immunologischen Abwehr einer Dermatophyteninfektion (eine Literaturstudie). Tierärztl Umschau 2004; 59: 694-699
• 22 Sloet van Oldruitenborgh-Oosterbaan M, Knottenbelt DC. Hauterkrankungen bei Pferden. Hannover: Schlütersche; 2009
• 23 Stadler S, Kainzbauer C, Haralambus R et al. Successful treatment of equine sarcoids by topical aciclovir application. Vet Rec 2011; 168 (7) 187
• 24 Studer S, Gerber V, Straub R et al. Prevalence of hereditary disease in three-year-old Swiss Warmblood horses. Schweiz Arch Tierheilkd 2007; 149 (4) 161-171